Home ACQUISITIONS and MERGERS

ACQUISITIONS and MERGERS

Boston Scientific Announces Agreement to Acquire Symetis for $435 Mil Up-Front Cash

Acquisition Will Expand Treatments for Patients with Valvular Heart Disease and Strengthen Company's Position in Structural Heart Globally.